Table 1.
Baseline characteristics and comorbidities of all patients with cardiogenic shock 2007—2017
| Total | Medical therapy | Mechanical circulatory support | |
|---|---|---|---|
| N | 383,983 | 333,459 | 50,524 |
| Age in years | 71.3 | 72.2 | 65.5 |
| Female gender | 147,711 (38.5%) | 133,426 (40.0%) | 14,286 (28.3%) |
| CAD | 179,740 (46.8%) | 140,581 (42.2%) | 39,159 (77.5%) |
| Hypertension | 141,339 (36.8%) | 121,935 (36.6%) | 19,404 (38.4%) |
| Previous AMI | 25,562 (6.7%) | 22,016 (6.6%) | 3546 (7.0%) |
| Previous CABG | 24,102 (6.3%) | 20,506 (6.2%) | 3596 (7.1%) |
| Previous cardiac surgery | 33,448 (8.7%) | 28,661 (8.6%) | 4787 (9.5%) |
| Peripheral vascular disease | 28,254 (7.4%) | 24,339 (7.3%) | 3915 (7.8%) |
| Carotid disease | 6236 (1.6%) | 4968 (1.5%) | 1268 (2.5%) |
| COPD | 38,772 (10.1%) | 35,072 (10.5%) | 3700 (7.3%) |
| Pulmonary hypertension | 28,302 (7.4%) | 23,563 (7.1%) | 4739 (9.4%) |
| Renal disease GFR < 15% | 14,860 (3.9%) | 13,611 (4.1%) | 1249 (2.5%) |
| Renal disease GFR < 30% | 20,210 (5.3%) | 18,575 (5.6%) | 1635 (3.2%) |
| Atrial fibrillation | 121,074 (31.5%) | 105,179 (31.5%) | 15,895 (31.5%) |
| Diabetes | 116,314 (30.3%) | 100,872 (30.3%) | 15,442 (30.6%) |
Presentation of baseline characteristics and comorbidities of all patients with cardiogenic shock 2007–2017 for the whole cohort, and grouped in medically treated or on mechanical circulatory support (MCS). The total case number is followed by the percentage